Clinical trial
Evaluation of Safety and Efficacy of the Absnow Absorbable ASD Closure System For Treating ASD Patients
NCT03601039 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Efficacy of the Absnow Absorbable ASD Closure System For Treating ASD Patients
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 25, 2018
- Completion date
- August 30, 2024
- Enrollment
- 165 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
atrial septal defect, heart septal defects, atrial